Handelsbanken Fonder Ab Vericel Corp Transaction History
Handelsbanken Fonder Ab
- $26.2 Billion
- Q4 2024
A detailed history of Handelsbanken Fonder Ab transactions in Vericel Corp stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 16,479 shares of VCEL stock, worth $816,699. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,479
Previous 15,479
6.46%
Holding current value
$816,699
Previous $654,000
38.38%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding VCEL
# of Institutions
293Shares Held
50.7MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$399 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$173 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$160 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$119 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$111 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.34B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...